Article Text

PDF
The significance of circulating levels of both cardiac troponin I and high-sensitivity C reactive protein for the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction
  1. S G Foussas,
  2. M N Zairis,
  3. S S Makrygiannis,
  4. S J Manousakis,
  5. F A Anastassiadis,
  6. C S Apostolatos,
  7. N G Patsourakos,
  8. M P Glyptis,
  9. J K Papadopoulos,
  10. D C Xenos,
  11. E N Adamopoulou,
  12. C D Olympios,
  13. S K Argyrakis
  1. Department of Cardiology, Tzanio Hospital, Piraeus, Greece
  1. Correspondence to:
    Dr M N Zairis
    Department of Cardiology, 40 Acti Themistokleous Street, Piraeus 18537, Greece; zairis{at}hellasnet.gr

Abstract

Objectives: To evaluate, using continuous 12-lead ECG ST-segment monitoring, the role of circulating levels of both cardiac troponin I (cTnI) and high-sensitivity C reactive protein (hs-CRP), on presentation, in the prediction of intravenous thrombolysis outcome in patients with ST-segment elevation myocardial infarction (STEMI).

Design and setting: Prospective observational study in a tertiary referral centre.

Patients: 786 consecutive patients with STEMI, who received intravenous thrombolysis in the first 6 h from index pain.

Main outcome measures: The incidence of failed thrombolysis and of cardiac death by 30 days. Failed thrombolysis was defined as the absence of abrupt and sustained ⩾50% ST-segment recovery in the first 90 min after the initiation of intravenous thrombolysis.

Results: The incidence of failed thrombolysis and 30-day cardiac death was 57.4% and 11.8%, respectively. By multivariate logistic regression analysis according to tertiles of both cTnI (RR, 1.5; 95% CI 1.1 to 1.8, p = 0.004 for highest vs middle third; 2.2, 1.9 to 3.5, p<0.001 for highest vs lowest third; 1.5, 1.2 to 1.8, p = 0.001 for middle vs lowest third) and hs-CRP (RR, 2.0, 95% CI, 1.6 to 2.2; p<0.001 for highest vs middle third; 2.6, 2.1 to 3.5, p<0.001 for highest vs lowest third; 1.3, 1.2 to 1.7, p = 0.02 for middle vs lowest third), were independently associated with failed thrombolysis. Moreover, by multivariate Cox regression analysis according to tertiles of both cTnI (HR 1.2, 95% CI 1.1 to 1.8, p = 0.03 for highest vs middle third; 1.5, 1.2 to 2.2, p = 0.004 for highest vs lowest third; 1.1, 0.6 to 1.4, p = 0.6 for middle vs lowest third) and hs-CRP (HR1.2, 95% CI 1.1 to 1.6, p = 0.04 for highest vs middle third; 1.7, 1.3 to 2.6, p = 0.001 for highest vs lowest third; 1.1, 0.9 to 2.1, p = 0.1 for middle vs lowest third), were independently related with an increased risk of 30-day cardiac death.

Conclusions: High circulating levels of both cTnI and hs-CRP are related with an independent increased risk of intravenous thrombolysis failure and 30-day cardiac death in patients who received intravenous thrombolysis in the first 6 h of STEMI.

  • CRP, C reactive protein
  • cTn (I or T), cardiac troponin (I or T)
  • hs-CRP, high-sensitivity C reactive protein
  • STEMI, ST-segment elevation myocardial infraction

Statistics from Altmetric.com

Footnotes

  • Published Online First 7 March 2007

  • Competing interests: None declared.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.